In May 2016, Pacific Northwest Research Institute (PNRI) and Indivumed GmbH (Indivumed), based in Hamburg, Germany, entered a strategic collaboration led by PNRI’s David Galas, PhD. The collaboration is designed to harness the power of molecular and clinical cancer data for tailoring successful treatments for individual cancer patients.
Indivumed’s global Cancer Database and Biobank contains more than 4.5 million biological data
PNRI is supported by
